Menu Search
Equities

Stryker Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SYK:STU

Stryker Corp

Actions
  • Price (EUR)307.70
  • Today's Change1.90 / 0.62%
  • Shares traded8.00
  • 1 Year change-16.97%
  • Beta0.8683
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

  • Revenue in USD (TTM)25.12bn
  • Net income in USD3.25bn
  • Incorporated1946
  • Employees56.00k
  • Location
    Stryker Corp1941 STRYKER WAYPORTAGE 49002United StatesUSA
  • Phone+1 (269) 385-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SYK:NYQ since
announced		Transaction
value
Guard Medical IncDeal completed22 Aug 202522 Aug 2025Deal completed-3.38%--
Data delayed at least 15 minutes, as of Feb 13 2026 15:47 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.